[Clinical features and gene mutations of 6 patients with carnitine palmitoyltransferase 1A deficiency]

Y Yu1, L H Shen2, W J Qiu1

  • 1Department of Pediatric Endocrinology and Genetic Metabolism, Shanghai Xinhua Children's Hospital, Shanghai Institute for Pediatric Research, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200092, China.

Zhonghua Yi Xue Za Zhi
|April 12, 2021
PubMed

Insights

Carnitine palmitoyltransferase 1A deficiency (CPT1A) diagnosis is improved by analyzing patient data and gene sequencing. Tandem mass spectrometry aids in early CPT1A screening and diagnosis.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Carnitine palmitoyltransferase 1A (CPT1A) deficiency is a rare metabolic disorder.
  • Understanding CPT1A deficiency is crucial for early diagnosis and management.

Purpose of the Study:

  • To analyze clinical, biochemical, and genetic data of CPT1A deficiency patients.
  • To enhance the understanding of CPT1A deficiency.
  • To identify novel mutations in the CPT1A gene.

Main Methods:

  • Retrospective analysis of clinical and biochemical data from six CPT1A deficiency patients.
  • Gene sequencing of the CPT1A gene.
  • Tandem mass spectrometry for carnitine and acyl carnitine analysis.

Main Results:

  • Six patients (5 male, 1 female; aged 1-8 years) were included.
  • Two patients detected via neonatal screening were asymptomatic; four presented with seizures.
  • Biochemical analysis revealed increased serum free carnitine (C0) and decreased C16/C18, with elevated C0/(C16+C18).
  • All patients had compound heterozygous CPT1A mutations, including two known and ten novel mutations (6 missense, 1 nonsense, 1 deletion, 2 splicing).

Conclusions:

  • Tandem mass spectrometry is valuable for early screening and diagnosis of CPT1A deficiency.
  • Identification of novel CPT1A mutations expands the known mutation spectrum.
  • Comprehensive analysis improves understanding of CPT1A deficiency's clinical and genetic landscape.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
495
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.2K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
528
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
121
Smooth Endoplasmic Reticulum01:21

Smooth Endoplasmic Reticulum

Smooth endoplasmic reticulum or smooth ER is a sub-organelle with specialized functions in animal cells and plant cells. It is often associated with the tubule morphology of the endoplasmic reticulum.
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
7.1K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
166